SCHEMBL5258491

SCHEMBL5258491

Nc1cc(Cl)ccc1NC(=O)Oc1cc(Cl)n[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 3/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ABL1 P00519 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5256987 0.90 MEN1 (0.42) HDAC1MEN1KMT2AABL1HDAC3
SCHEMBL5257442 0.86 MEN1 (0.43) HDAC1MEN1KMT2AHDAC3HDAC4
SCHEMBL5253672 0.77 PDPK1 (0.39) HDAC1HDAC3HDAC2JAK2POLB
SCHEMBL5254960 0.71 KMT2A (0.34) KMT2A
SCHEMBL551648 0.68 HDAC1 (0.50) HDAC1MEN1KMT2AABL1KDM4E
SCHEMBL30485007 0.68 HDAC1 (0.50) HDAC1MEN1KMT2AABL1KDM4E
SCHEMBL3953891 0.67 HDAC1 (0.55) HDAC1MEN1KMT2AABL1KDM4E
SCHEMBL13987014 0.67 GSK3B (0.50) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL29904755 0.66 HDAC1 (0.70) HDAC1KMT2AABL1HDAC3HDAC2
SCHEMBL9651918 0.66 HDAC1 (0.70) HDAC1KMT2AABL1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725543-B1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-28 — — EP disclosed
EP-1725543-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2006-11-29 — — EP disclosed
WO-2005085230-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-09-15 — — WO disclosed
Send feedback